Channelopathies, painful neuropathy, and diabetes: which way does the causal arrow point?

Trends Mol Med. 2014 Oct;20(10):544-50. doi: 10.1016/j.molmed.2014.06.003. Epub 2014 Jul 5.

Abstract

Diabetes mellitus, a major global health problem, is commonly associated with painful peripheral neuropathy, which can substantially erode quality of life. Despite its clinical importance, the pathophysiology of painful diabetic neuropathy is incompletely understood. It has traditionally been thought that diabetes may cause neuropathy in patients with appropriate genetic makeup. Here, we propose a hypothesis whereby painful neuropathy is not a complication of diabetes, but rather occurs as a result of mutations that, in parallel, confer vulnerability to injury in pancreatic β cells and pain-signaling dorsal root ganglion (DRG) neurons. We suggest that mutations of sodium channel NaV1.7, which is present in both cell types, may increase susceptibility for development of diabetes via β cell injury and produce painful neuropathy via a distinct effect on DRG neurons.

Keywords: Na(V)1.7; diabetes mellitus; diabetic neuropathy; painful neuropathy; sodium channelopathy; β cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Channelopathies / etiology
  • Channelopathies / genetics*
  • Diabetic Neuropathies / etiology
  • Diabetic Neuropathies / genetics*
  • Diabetic Neuropathies / pathology
  • Ganglia, Spinal / metabolism
  • Ganglia, Spinal / pathology
  • Genetic Predisposition to Disease
  • Humans
  • Insulin-Secreting Cells / metabolism
  • Insulin-Secreting Cells / pathology
  • Mutation
  • NAV1.7 Voltage-Gated Sodium Channel / genetics*
  • Pain / etiology
  • Pain / genetics*
  • Peripheral Nervous System Diseases / etiology
  • Peripheral Nervous System Diseases / genetics*

Substances

  • NAV1.7 Voltage-Gated Sodium Channel
  • SCN9A protein, human

Supplementary concepts

  • Neuropathy, Painful